Evaluation of clinical disease activity, work productivity, and psychological influence of biologics for rheumatoid arthritis or psoriatic arthritis
Not Applicable
- Conditions
- Rheumatoid arthritis, Psoriatic arthritis
- Registration Number
- JPRN-UMIN000023153
- Lead Sponsor
- Department of Immunotherapy Management, Graduate School of Medicine, University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who refuse to participate this study 2) Patients for whom the physicians do not think suitable for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in variable parameters of biologics for rheumatoid arthritis or psoriatic arthritis. Clinical disease activity to be assessed using DAS-ESR, DAS-CRP, SDAI, CDAI. Work productivity to be assessed using WPAI. Psychological influence to be assessed using WHO-5
- Secondary Outcome Measures
Name Time Method Correlation between clinical disease activity and work productivity and psychological influence of biologics for rheumatoid arthritis or psoriatic arthritis